The Potential Dangers of Using MDMA for Psychotherapy

REFERENCES

• Benningfield, M.M. & Cowan, R.L. 2013. Brain serotonin function in MDMA (ecstasy) users: Evidence for persisting neurotoxicity. Neuropsychopharmacology 38: 253–5.
   PubMed Web of Science ®Google Scholar
• Bouso, J.C. 2001. Using MDMA in the treatment of post-traumatic stress disorder. In: J. Holland (Ed.) Ecstasy: The Complete Guide. Rochester, VT: Park Street Press.
   Google Scholar
• Brière, F.N.; Fallu, J.S.; Janosz, M. & Pagani, L.S. 2012. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students. Journal of Epidemiology and Community Health 66: 990–4.
   PubMed Web of Science ®Google Scholar
• Caton, C.L.; Samet, S. & Hasin, D.S. 2000. When acute-stage psychosis and substance use co-occur: Differentiating substance-induced and primary psychotic disorders. Journal of Psychiatric Practice 6: 256–66.
   PubMedGoogle Scholar
• Cohen, R.S. 1998. The Love Drug: Marching to the Beat of Ecstasy. New York: Haworth Medical Press.
   Google Scholar
• Connor, T.J. 2004. Methylenedioxymethamphetamine (MDMA, “ecstasy”): A stressor on the immune system. Immunology 111: 357–67.
   PubMed Web of Science ®Google Scholar
• Cowan, R.L. 2007. Neuroimaging research in human MDMA users: A review. Psychopharmacology 189: 539–56.
   PubMed Web of Science ®Google Scholar
• Curran, H.V.; Rees, H.; Hoare, T.; Hoshi, R. & Bond, A. 2004. Empathy and aggression: Two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology 173: 425–33.
   PubMed Web of Science ®Google Scholar
• Curran, H.V. & Travill, R.A. 1997. Mood and cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”): Weekend “high” followed by mid-week “low.” Addiction 92: 821–31.
   PubMed Web of Science ®Google Scholar
• Davison, D. & Parrott, A.C. 1997. Ecstasy in recreational users: Self-reported psychological and physiological effects. Human Psychopharmacology 12: 91–7.
   Web of Science ®Google Scholar
• Degenhardt, L. & Hall, W. 2009. The Health and Psychological Effects of “Ecstasy” (MDMA) Use. National Drug Addiction Research Centre Monograph no. 62. Sydney, Australia: University of New South Wales.
   Google Scholar
• Dittrich, A. 1994. Psychological aspects of altered states of consciousness of the LSD type. In: A. Pletscher & D. Ladewig (Eds.) Fifty Years of LSD: Current Status and Future Perspectives of Hallucinogens. New York: Parthenon Publishing.
   Google Scholar
• Doblin, R. 2002. A clinical plan for MDMA (ecstasy) in the treatment of posttraumatic stress disorder (PTSD): Partnering with the FDA. Journal of Psychoactive Drugs 34: 185–94.
   PubMed Web of Science ®Google Scholar
• Dumont, G.J. & Verkes, R.J. 2006. A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. Journal of Psychopharmacology 20: 176–87.
   PubMed Web of Science ®Google Scholar
• Fox, H.; Parrott, A.C. & Turner, J.J.D. 2001. Ecstasy/MDMA related cognitive deficits: A function of dosage rather than awareness of problems. Journal of Psychopharmacology 15: 273–81.
   PubMed Web of Science ®Google Scholar
• Fox, H.C.; McLean, A.; Turner, J.J.D.; Parrott, A.C.; Rogers, R. & Sahakian, B.J. 2002. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users. Psychopharmacology 162: 203–14.
   PubMed Web of Science ®Google Scholar
• Green, A.R.; Mechan, A.O.; Elliott, J.M.; O’Shea, E. & Colado, M.I. 2003. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacological Reviews 55: 463–508.
   PubMed Web of Science ®Google Scholar
• Greer, G. & Tolbert, R. 1986. Subjective reports of the effects of MDMA in a clinical setting. Journal of Psychoactive Drugs 18: 319–27.
   PubMed Web of Science ®Google Scholar
• Greer, G. & Tolbert, R. 1990. The therapeutic use of MDMA. In: S.J. Peroutka (Ed.) The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. New York: Kluwer.
   Google Scholar
• Halpern, J.H.; Pope, H.G.; Sherwood, A.R.; Barry, S.; Hudson, J.I. & Yurgelun-Todd, D. 2004. Residual effects of illicit 3,4-methylenedioxymethamphetamine in individuals with minimal exposure to other drugs. Drug and Alcohol Dependence 75: 135–47.
   PubMed Web of Science ®Google Scholar
• Jones, K.A.; Callan, F.; Blagrove, M.T. & Parrott, A.C. 2008. Sleep, energy and self-rated cognition across 7 nights following recreational ecstasy/MDMA use. Sleep and Hypnosis 10: 16–28.
   Google Scholar
• Kish, S.J.; Lerch, J.; Furukawa, Y.; Tong, J.; McCluskey, T.; Wilkins, D.; Houle, S.; Meyer, J.; Mundo, E.; Wilson, A.A.; Rusjan, P.M.; Saint-Cyr, J.A.; Guttman, M.; Collins, D.L.; Shapiro, C.; Warsh, J.J. & Boileau, I. 2010. Decreased cerebral cortical serotonin transporter binding in ecstasy users: A positron emission tomography/[(11)C] DASB and structural brain imaging study. Brain 133: 1779–97.
   PubMed Web of Science ®Google Scholar
• Liechti, M.E.; Gamma, A. & Vollenweider, F.X. 2001. Gender differences in the subjective effects of MDMA. Psychopharmacology 154: 161–8.
   PubMed Web of Science ®Google Scholar
• MacInnes, N.; Handley, S.L. & Harding, G.F.A. 2001. Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. Journal of Psychopharmacology 15: 181–6.
   PubMed Web of Science ®Google Scholar
• McCann, U.D.; Eligulashvili, V. & Ricaurte, G.A. 2000. 3,4 methylenedioxymethamphetamine (“ecstasy”)-induced serotonin neurotoxicity: Clinical studies. Neuropsychobiology 42: 11–16.
   PubMed Web of Science ®Google Scholar
• McCann, U.D. & Ricaurte, G.A. 2007. Effects of (+/-) 3,4-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms. Scientific World Journal 7: 231–8.
   Google Scholar
• Metzner, R. & Adamson, S. 2001. Using MDMA in healing, psychotherapy and spiritual practice. In: J. Holland (Ed.) Ecstasy the Complete Guide. Rochester, VT: Park Street Press.
   Google Scholar
• O’Regan, M.C. & Clow, A. 2004. Decreased pain tolerance and mood in recreational users of MDMA. Psychopharmacology 173: 446–51.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 1999. Does cigarette smoking cause stress? American Psychologist 54: 817–20.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 2001. Human psychopharmacology of ecstasy (MDMA): A review of fifteen years of empirical research. Human Psychopharmacology 16: 557–77.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 2004. MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology 50: 329–35.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 2006. MDMA in humans: Factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bio-energetic stress. Journal of Psychopharmacology 20: 147–63.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 2007. The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): An evidence-based review. Psychopharmacology 191: 181–93.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 2008. Drug taking – for better or for worse? Psychologist 21: 924–27.
   Web of Science ®Google Scholar
• Parrott, A.C. 2009. Cortisol and MDMA (3,4-methylenedioxymethamphetamine): Neurohormonal aspects of bioenergetic-stress in ecstasy users. Neuropsychobiology 60: 148–58.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 2010. Conscious awareness versus optimistic beliefs in recreational ecstasy/MDMA users. In: E. Perry, D. Collerton, F. LeBeau & H.E. Ashton (Eds.) New Horizons in the Neuroscience of Consciousness. Amsterdam: John Benjamin’s Publishers.
   Google Scholar
• Parrott, A.C. 2012. MDMA and 5-HT neurotoxicity: The empirical evidence for its adverse effects in humans—no need for translation. British Journal of Pharmacology 166: 1518–20.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 2013a. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational “ecstasy” users. Neuroscience and Biobehavioral Reviews 37: 1466–84.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. 2013b. Human psychobiology of MDMA or “ecstasy”: An overview of 25 years of empirical research. Human Psychopharmacology 28: 289–307.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. in press. MDMA is certainly damaging after 25 years of empirical research: A reply and refutation of Doblin et al. (2013). Human Psychopharmacology.
   Web of Science ®Google Scholar
• Parrott, A.C.; Gibbs, A.; Scholey, A.B.; King, R.; Owens, K.; Swann, P.; Ogden, E. & Stough, C. 2011. MDMA and methamphetamine: Some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology 215: 527–36.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C. & Lasky, J. 1998. Ecstasy (MDMA) effects upon mood and cognition: Before, during, and after a Saturday night dance. Psychopharmacology 139: 261–68.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C.; Milani, R.; Parmar, R. & Turner, J.J.D. 2001. Ecstasy polydrug users and other recreational drug users in Britain and Italy: Psychiatric symptoms and psychobiological problems. Psychopharmacology 159: 77–82.
   PubMed Web of Science ®Google Scholar
• Parrott, A.C.; Morinan, A.; Moss, M. & Scholey, A. 2004. Understanding Drugs and Behaviour. Chichester, UK: Wiley.
   Google Scholar
• Parrott, A.C.; Sands, H.R.; Jones, L.; Clow, A.; Evans, P.; Downey, L.A. & Stalder, T. in press. Increased cortisol in hair of recent ecstasy/MDMA users. European Journal of Neuropsychopharmacology.
   Google Scholar
• Parrott, A.C. & Yeomans, M. 1995. Wobble, rave, inhale or crave. The Psychologist (July): 305.
   Google Scholar
• Peroutka, S.J.; Newman, H. & Harris, H. 1988. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1: 273–7.
   PubMed Web of Science ®Google Scholar
• Reid, L.W.; Elifson, K.W. & Sterk, C.E. 2007. Hug drug or thug drug? Ecstasy use and aggressive behavior. Violence and Victims 22: 104–19.
   PubMedGoogle Scholar
• Rodgers, J.; Buchanan, T.; Pearson, C.; Parrott, A.C.; Ling, J.; Heffernan, T.M. & Scholey, A.B. 2006. Differential experiences of the psychobiological sequelae of ecstasy use: Quantitative and qualitative data from an internet study. Journal of Psychopharmacology 20: 437–46.
   PubMed Web of Science ®Google Scholar
• Rodgers, J.; Buchanan, T.; Scholey, A.B.; Heffernan, T.M.; Ling, J. & Parrott, A.C. 2003. Patterns of drug use and the influence of gender on self reports of memory ability in ecstasy users: A web based study. Journal of Psychopharmacology 17: 379–86.
   PubMed Web of Science ®Google Scholar
• Rugani, F.; Bacciardi, S.; Rovai, L.; Pacini, M.; Maremmani, A.G.I.; Deltito, J.; Dell’Osso, L. & Maremmani, I. 2012. Symptomatological features of patients with and without ecstasy use during their first psychotic episode. International Journal of Research into Public Health 9: 2283–92.
   PubMed Web of Science ®Google Scholar
• Schifano, F. 2000. Potential human neurotoxicity of MDMA (“ecstasy”): Subjective self-reports, evidence form an Italian drug addiction centre and clinical case studies. Neuropsychobiology 42: 25–33.
   PubMed Web of Science ®Google Scholar
• Scholey, A.B.; Owen, L.; Gates, J.; Rodgers, J.; Buchanan, T.; Ling, J.; Heffernan, T.; Swan, P.; Stough, C. & Parrott, A.C. 2011. Hair MDMA samples are consistent with reported ecstasy use: Findings from a study investigating effects of ecstasy on mood and memory. Neuropsychobiology 63: 15–21.
   PubMed Web of Science ®Google Scholar
• Shulgin, A.T. 1986. The background and chemistry of MDMA. Journal of Psychoactive Drugs 18: 291–304.
   PubMed Web of Science ®Google Scholar
• Soar, K.; Turner, J.J.D. & Parrott, A.C. 2001. Psychiatric disorders in recreational ecstasy (MDMA) users: A literature review focusing upon personal predisposition factors and drug histories. Human Psychopharmacology 16: 641–46.
   PubMed Web of Science ®Google Scholar
• Solowij, N.; Hall, W. & Lee, N. 1992. Recreational MDMA use in Sydney: A profile of ecstasy users and their experiences with the drug. British Journal of Addiction 87: 1161–72.
   PubMedGoogle Scholar
• Topp, L.; Hando, J.; Dillon, P.; Roche, A. & Solowij, N. 1999. Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence 55: 105–15.
   PubMed Web of Science ®Google Scholar
• Turner, J.J.D.; Nicolas, L. & Parrott, A.C. 1998. Reduced calorie intake in the week following weekend MDMA (ecstasy) use. Journal of Psychopharmacology 12: a43.
   Google Scholar
• Turner, J.J.D.; Parrott, A.C.; Moore, D.G.; Goodwin, J.; Fulton, S.; Min, M.O. & Singer, L.T. 2013. Reduced depression after quitting ecstasy/MDMA: Psychiatric gains in young mothers following the cessation of stimulant drug use. Second International Conference on Novel Psychoactive Substances, Swansea, Wales, UK, Conference Abstract.
   Google Scholar
• Verheyden, S.L.; Maidment, R.; Curran, H.V. 2003. Quitting ecstasy: An investigation of why people stop taking the drug and their subsequent mental health. Journal of Psychopharmacology 17: 371–78.
   PubMed Web of Science ®Google Scholar
• Verkes, R.J.; Gigsman, H.J.; Pieters, M.S.M.; Schoemaker, R.C.; de Visser, S. & Kuijpers, M. 2001. Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 53: 196–202.
   Web of Science ®Google Scholar
• Vollenweider, F.X.; Gamma, A.; Liechti, M. & Huber, T. 1998. Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19: 241–51.
   PubMed Web of Science ®Google Scholar
• Wareing, M.; Fisk, J.E. & Murphy, P.N. 2000. Working deficits in current and previous users of MDMA (“ecstasy”). British Journal of Psychology 91: 181–8.
   PubMed Web of Science ®Google Scholar